Abstract-To explore the role of angiotensin II Type 1 receptor-associated protein (ATRAP) in vascular remodeling, we developed transgenic mice for mouse ATRAP cDNA and examined remodeling after inflammatory vascular injury induced by polyethylene cuff placement. In ATRAP transgenic (ATRAP-Tg) mice, ATRAP mRNA was increased 3-to 4-fold in the heart, aorta, and femoral artery. ATRAP-Tg mice showed no significant change in body weight, systolic blood pressure, heart rate, and heart/body weight ratio. However, cell proliferation and neointimal formation in the injured artery were attenuated in ATRAP-Tg mice. The increase in NADPH oxidase activity and the expression of p22 phox , a reduced nicotinamide-adenine dinucleotide/reduced nicotinamide-adenine dinucleotide phosphate oxidase subunit, after cuff placement was also attenuated in ATRAP-Tg mice. Moreover, activation of extracellular signal-regulated kinase, signal transducer and activator of transcription 1, and signal transducer and activator of transcription 3 after cuff placement was significantly reduced in ATRAP-Tg mice. Pressor response and cardiac hypertrophy induced by angiotensin II infusion and pressure overload were also attenuated in ATRAP-Tg mice. These results suggest that ATRAP plays an important role in vascular remodeling as a negative regulator. Previous reports indicate that the intracellular carboxylterminal tail of the receptor plays an important role in activation of receptor-coupled G protein and internalization of the AT 1 receptor. [1][2][3][4][5][6] We cloned a novel AT 1 receptorassociated protein (ATRAP) using a yeast 2-hybrid screening system. 7 ATRAP has 3 transmembrane domains and interacts with the intracellular carboxyl-terminal domain of the AT 1 receptor, but it does not interact with the AT 2 receptor, m 3 muscarinic receptor, bradykinin B 2 receptor, endothelin ETB receptor, or  2 -adrenergic receptor. It is reported that ATRAP modulates AT 1 receptor function in COS-7 cells, human embryonic kidney 293 cells, and cultured mouse cardiomyocytes. Overexpression of ATRAP significantly decreases the number of AT 1 receptors on the cell surface and also decreases the degree of p38 mitogen-activated protein kinase phosphorylation, activity of the c-fos promoter, and protein synthesis on Ang II treatment. [7][8][9] We also reported that overexpression of ATRAP in cultured vascular smooth muscle cells (VSMCs) enhanced internalization of the AT 1 receptor and attenuated DNA synthesis and activation of extracellular signal-regulated kinase (ERK), Akt, and signal transducer and activator of transcription (STAT) induced by Ang II. 10 Polyethylene cuff placement around the femoral artery induces inflammatory vascular injury and remodeling responses accompanied by an increase in AT 1 and AT 2 receptor expression. VSMC proliferation, neointimal formation, inflammatory response, and oxidative stress in vascular injury were significantly attenuated in AT 1 a receptor-deficient mice. [11][12][13] Moreover, administration of an AT 1 receptor bloc...